We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more
LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN β IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.6 | -9.55414012739 | 6.28 | 6.5 | 5.54 | 38231 | 5.89673785 | CS |
4 | -0.17 | -2.90598290598 | 5.85 | 6.5 | 5 | 49629 | 5.70399424 | CS |
12 | 0.72 | 14.5161290323 | 4.96 | 6.9 | 4.23 | 70531 | 5.49304068 | CS |
26 | -2.92 | -33.9534883721 | 8.6 | 9.2 | 3.8181 | 292314 | 6.72629163 | CS |
52 | -2.208 | -27.9918864097 | 7.888 | 12 | 3.8181 | 606796 | 7.39825241 | CS |
156 | -95.12 | -94.3650793651 | 100.8 | 122.4 | 3.8181 | 544833 | 31.17897992 | CS |
260 | -191.72 | -97.1225937183 | 197.4 | 356.4 | 3.8181 | 485101 | 54.34770892 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions